3,5-Difluoropyridine-2-carboxylic acid → HCID 46204007, compound
Reaction equation
Cl.[CH3:2][O:3][C:4]1[CH:5]=[C:6]([C:12]2[C:13]([CH3:25])([CH3:24])[C:14](=[O:23])[N:15]([CH:17]3[CH2:22][CH2:21][NH:20][CH2:19][CH2:18]3)[N:16]=2)[CH:7]=[CH:8][C:9]=1[O:10][CH3:11].[F:26][C:27]1[C:28]([C:34](O)=[O:35])=[N:29][CH:30]=[C:31]([F:33])[CH:32]=1>>[F:26][C:27]1[C:28]([C:34]([N:20]2[CH2:21][CH2:22][CH:17]([N:15]3[C:14](=[O:23])[C:13]([CH3:25])([CH3:24])[C:12]([C:6]4[CH:7]=[CH:8][C:9]([O:10][CH3:11])=[C:4]([O:3][CH3:2])[CH:5]=4)=[N:16]3)[CH2:18][CH2:19]2)=[O:35])=[N:29][CH:30]=[C:31]([F:33])[CH:32]=1Participants
3
Procedure
The title compound is prepared analogously as described for GP2-WU2 using 5-(3,4-dimethoxyphenyl)-4,4-dimethyl-2-(piperidin-4-yl)-2,4-dihydro-3H-pyrazol-3-one (compound B1) and 3,5-difluoropyridine-2-carboxylic acid as starting compounds. The crude product is purified by chromatography (amino phase silica gel and DCM) to yield the title compound.
Workup
- customThe title compound is prepared analogously
- customThe crude product is purified by chromatography (amino phase silica gel and DCM)
Sources & evidence
- ORD record
- ord-d7741ac96b0d4daea8abfcdc0b819f06
- Source dataset
- uspto-grants-2016_05
- Patent number
- US09340522B2
Reaction notes
Loading…